Clinical Trial Update: Fresolimumab In Systemic Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 study of fresolimumab in diffuse systemic sclerosis conducted by Boston University has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Systemic Sclerosis

Drugs mentioned

• Fresolimumab (Fresolimumab)

Snippet

Sponsor: Boston University | Conditions: Diffuse Systemic Sclerosis | Phase 1 | Status: COMPLETED